Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find a Doctor
Alex Huang, MD

Alex Huang, MD

  • Specialty: Pediatric Hematology and Oncology
    View Expertise
  • Languages Spoken: English

Biography: Alex Huang, MD

Expertise

  • Pediatric Hematology
  • Pediatric Oncology

Titles

  • Program Director, Pediatric Hematology and Oncology, UH Cleveland Medical Center
  • Associate Professor of Pathology, CWRU School of Medicine
  • Professor of Pediatrics, CWRU School of Medicine
  • Theresia G. and Stuart F. Kline Family Foundation Chair in Pediatric Oncology, UH Rainbow Babies & Children's Hospital

Certifications & Memberships

  • Pediatric Hematology-Oncology - American Board of Pediatrics
  • Pediatrics - American Board of Pediatrics

Education

Post Doctorate Training | Immunology
Immunology - National Institute Of Allergy And Infectious Diseases (2003 - 2006)

Fellowship | Pediatric Hematology/Oncology
Pediatric Hematology/Oncology - National Cancer Institute (Nci) (2000 - 2003)

Fellowship | Pediatric Hematology/Oncology
Pediatric Hematology/Oncology - Johns Hopkins Hospital (2000 - 2003)

Residency | Pediatrics
Pediatrics - Johns Hopkins Hospital (1998 - 2000)

Internship | Pediatrics
Pediatrics - Johns Hopkins Hospital (1997 - 1998)

Medical Education
Johns Hopkins University School Of Medicine (1997)

Undergraduate
University Of Chicago (1990)

Other Education
University Of Chicago (1990)

Featured Videos

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Alex Huang did not disclose any Outside Relationships with Industry.